Pfizer Inc v. Cipla, Ltd
Pfizer Inc v. Cipla, Ltd is a federal patent - anda lawsuit filed on 10/16/2020 in the District Court, D. Delaware. The case was terminated on 05/03/2021.
A lawsuit records allegations and procedural activity. Being named as a party does not establish liability, wrongdoing, or the merits of any claim.
- Court
- District Court, D. Delaware (D. Del.)
Official Court Website → - Assigned judge
- Colm F. Connolly · 1,962 cases in index
- Docket number
- 1:20-cv-01393
- Cause
- 35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement - Nature of suit
- 835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 10/16/2020
- Date terminated
- 05/03/2021
1,126 Patent - ANDA cases in this court are indexed here.
Parties
- plaintiff · Pfizer, Inc Pharmaceuticals & Biotechnology · 12903 cases
- defendant · Cipla Ltd · 25 cases
Other Cases Naming This Defendant
CIPLA LTD is named in 25 federal civil cases in this index. Recent Patent - ANDA cases naming the same defendant:
About Patent - ANDA Lawsuits
ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
Frequently Asked Questions
What is Pfizer Inc v. Cipla, Ltd?
Pfizer Inc v. Cipla, Ltd is a federal patent - anda lawsuit filed on 10/16/2020 in the District Court, D. Delaware. The case was terminated on 05/03/2021. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What type of case is this?
It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What court is the case in?
The case is in the District Court, D. Delaware, docket number 1:20-cv-01393.
When was the case filed?
Pfizer Inc v. Cipla, Ltd was filed on 10/16/2020. It was terminated on 05/03/2021.
What law is the case brought under?
The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.
Other Cases Involving These Parties
Related Patent - ANDA Cases
Source: public U.S. federal court record — docket 18545774 in the CourtListener/RECAP archive (verify this docket), court docket number 1:20-cv-01393 on PACER. Court, party, date and judge fields are reproduced from that record; case-type categories, statute decoding and all aggregate figures are derived by Docket Nexus (methodology).